"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 10 | 10 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 12 | 12 |
| 2007 | 0 | 9 | 9 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 8 | 8 |
| 2010 | 0 | 13 | 13 |
| 2011 | 0 | 12 | 12 |
| 2012 | 0 | 22 | 22 |
| 2013 | 0 | 16 | 16 |
| 2014 | 0 | 12 | 12 |
| 2015 | 0 | 16 | 16 |
| 2016 | 0 | 47 | 47 |
| 2017 | 4 | 621 | 625 |
| 2018 | 0 | 651 | 651 |
| 2019 | 1 | 211 | 212 |
| 2020 | 2 | 184 | 186 |
| 2021 | 0 | 113 | 113 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood. 2021 11 04; 138(18):1768-1773.
-
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. J Natl Cancer Inst. 2021 11 02; 113(11):1484-1494.
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
-
In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients. J Clin Invest. 2021 10 01; 131(19).
-
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J Clin Invest. 2021 10 01; 131(19).
-
Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis. JAMA Intern Med. 2021 10 01; 181(10):1306-1314.
-
The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis-A Nested Case-Control Study. Dermatitis. 2021 Oct 01; 32(1S):S45-S52.
-
CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients. JCI Insight. 2021 09 22; 6(18).
-
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. PLoS One. 2021; 16(8):e0256544.
-
Clinical outcomes in cancer patients with COVID-19. Cancer Rep (Hoboken). 2021 12; 4(6):e1413.